| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Division of Applied Toxicology, Institute of Toxicology, University of Mainz, D-55131 Mainz, Germany
In the therapy of various kinds of tumors, methylating agents generating O6-methylguanine (O6MeG) in DNA are used. We studied the molecular mechanism of cell death induced by these agents by comparing isogenic cell lines proficient (MGMT+) and deficient (MGMT-) for the DNA repair protein alkyltransferase and exhibiting the tolerance phenotype. Hypersensitivity to methylation-induced cell killing of MGMT- cells is attributable to the potent induction of apoptosis. We show that apoptosis is a late event occurring >48 h after methylation. It was preceded by decrease in Bcl-2 protein level and accompanied by activation of caspase-9 and caspase-3. We also observed cytochrome c release and hypophosphorylation of Bad. Other members of the Bcl-2 family (Bag-1, Bak, Bax, and Bcl-xL) were not altered in expression. Transfection of MGMT- cells with bcl-2 protected against methylation-induced apoptosis, indicating that Bcl-2 plays a key role in the response. Induction of apoptosis in MGMT- cells was not triggered by Fas and Fas ligand (CD95, Apo-1) because both proteins remained unaltered in expression and receptor-proximal caspase-8 was not activated after methylation. Also, inhibition of caspase-8 was ineffective in modifying the apoptotic response, whereas inhibition of caspase-3 and caspase-9 blocked apoptosis. Tolerant cells that are unable to repair O6MeG and are impaired in mismatch repair were less sensitive regarding the induction of apoptosis and Bcl-2 decline, supporting the view that O6MeG-induced apoptosis requires mismatch repair. The ultimate O6MeG-derived lesions triggering the apoptotic pathway are likely to be DNA double-strand breaks, which were significantly formed in MGMT- but not in MGMT+ and tolerant cells and which preceded apoptosis. Overall, the data indicate that O6MeG induces apoptosis via secondary lesions that trigger Bcl-2 decline, cytochrome c release, and caspase-9 and caspase-3 activation independently of Fas/Fas ligand and p53, for which the cells are mutated.
This article has been cited by other articles:
![]() |
M. E. Hegi, L. Liu, J. G. Herman, R. Stupp, W. Wick, M. Weller, M. P. Mehta, and M. R. Gilbert Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity J. Clin. Oncol., September 1, 2008; 26(25): 4189 - 4199. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanada, M. Hidaka, Y. Takagi, T. Y. Takano, Y. Nakatsu, T. Tsuzuki, and M. Sekiguchi Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis Carcinogenesis, December 1, 2007; 28(12): 2657 - 2663. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. Kim, B. Rajasekaran, and K. D. Brown MLH1- and ATM-dependent MAPK Signaling Is Activated through c-Abl in Response to the Alkylator N-Methyl-N'-nitro-N'-nitrosoguanidine J. Biol. Chem., November 2, 2007; 282(44): 32021 - 32031. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stupp, M. E. Hegi, M. R. Gilbert, and A. Chakravarti Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions J. Clin. Oncol., September 10, 2007; 25(26): 4127 - 4136. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yamini, X. Yu, M. E. Dolan, M. H. Wu, D. W. Kufe, and R. R. Weichselbaum Inhibition of Nuclear Factor-{kappa}B Activity by Temozolomide Involves O6-Methylguanine Induced Inhibition of p65 DNA Binding Cancer Res., July 15, 2007; 67(14): 6889 - 6898. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O'Brien and R. Brown Signalling cell cycle arrest and cell death through the MMR System Carcinogenesis, April 1, 2006; 27(4): 682 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Fox, D. T. Leahy, R. Geraghty, H. E. Mulcahy, D. Fennelly, J. M. Hyland, D. P. O'Donoghue, and K. Sheahan Mutually Exclusive Promoter Hypermethylation Patterns of hMLH1 and O6-Methylguanine DNA Methyltransferase in Colorectal Cancer J. Mol. Diagn., February 1, 2006; 8(1): 68 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hidaka, Y. Takagi, T. Y. Takano, and M. Sekiguchi PCNA-MutS{alpha}-mediated binding of MutL{alpha} to replicative DNA with mismatched bases to induce apoptosis in human cells Nucleic Acids Res., October 4, 2005; 33(17): 5703 - 5712. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Peterson-Roth, M. Reynolds, G. Quievryn, and A. Zhitkovich Mismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage Mol. Cell. Biol., May 1, 2005; 25(9): 3596 - 3607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hegi, A.-C. Diserens, T. Gorlia, M.-F. Hamou, N. de Tribolet, M. Weller, J. M. Kros, J. A. Hainfellner, W. Mason, L. Mariani, et al. MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma N. Engl. J. Med., March 10, 2005; 352(10): 997 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Barvaux, P. Lorigan, M. Ranson, A. M. Gillum, R. S. McElhinney, T. B. H. McMurry, and G. P. Margison Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase Mol. Cancer Ther., October 1, 2004; 3(10): 1215 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gonzalez-Suarez, F. A. Goytisolo, J. M. Flores, and M. A. Blasco Telomere Dysfunction Results in Enhanced Organismal Sensitivity to the Alkylating Agent N-Methyl-N-Nitrosourea Cancer Res., November 1, 2003; 63(21): 7047 - 7050. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Petrin, A. Baker, S. G. Coupland, P. Liston, M. Narang, K. Damji, B. Leonard, V. A. Chiodo, A. Timmers, W. Hauswirth, et al. Structural and Functional Protection of Photoreceptors from MNU-Induced Retinal Degeneration by the X-Linked Inhibitor of Apoptosis Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2757 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Tomicic, C. Friedrichs, M. Christmann, P. Wutzler, R. Thust, and B. Kaina Apoptosis Induced by (E)-5-(2-Bromovinyl)-2'-deoxyuridine in Varicella Zoster Virus Thymidine Kinase-Expressing Cells Is Driven by Activation of c-Jun/Activator Protein-1 and Fas Ligand/Caspase-8 Mol. Pharmacol., February 1, 2003; 63(2): 439 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Adamson, W.-J. Kim, S. Shangary, R. Baskaran, and K. D. Brown ATM Is Activated in Response to N-Methyl-N'-nitro- N-nitrosoguanidine-induced DNA Alkylation J. Biol. Chem., October 4, 2002; 277(41): 38222 - 38229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Page, S. O'Brien, C. R. Jefcoate, and C. J. Czuprynski 7,12-Dimethylbenz[a]anthracene Induces Apoptosis in Murine Pre-B Cells through a Caspase-8-Dependent Pathway Mol. Pharmacol., August 1, 2002; 62(2): 313 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christmann, M. T. Tomicic, and B. Kaina Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutS{alpha} mismatch-binding activity Nucleic Acids Res., May 1, 2002; 30(9): 1959 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mohr, X. Xi, J. Tang, and T. S. Kern Caspase Activation in Retinas of Diabetic and Galactosemic Mice and Diabetic Patients Diabetes, April 1, 2002; 51(4): 1172 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ochs, J. Lips, S. Profittlich, and B. Kaina Deficiency in DNA Polymerase {beta} Provokes Replication-dependent Apoptosis via DNA Breakage, Bcl-2 Decline and Caspase-3/9 Activation Cancer Res., March 1, 2002; 62(5): 1524 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lips and B. Kaina DNA double-strand breaks trigger apoptosis in p53-deficient fibroblasts Carcinogenesis, April 1, 2001; 22(4): 579 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Dunkern and B. Kaina Cell Proliferation and DNA Breaks Are Involved in Ultraviolet Light-induced Apoptosis in Nucleotide Excision Repair-deficient Chinese Hamster Cells Mol. Biol. Cell, January 1, 2002; 13(1): 348 - 361. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |